Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
Home > Patient Care > Accommodations near UCLA Medical Center   
Accommodations near UCLA Medical Center
Overall survival rates and a realistic evaluation of how UCLA Neuro-Oncology cares for patients with a


Audio Presentations
University of California, Los Angeles Neuro-Oncology : A Comprehensive Brain Tumor Program
Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Research and Markets: Metastatic Brain Tumor - Pipeline Review, H1 2012
Tue, 08 May 2012 09:01:00 -0700
Brain Tumor Patient Community Delivers Priorities to Congress: Invest in Research and Ensure Access to Oral Chemotherapy
Mon, 07 May 2012 05:02:47 -0700
She's a brain tumor survivor and she wants to tell the world her story
Wed, 16 May 2012 17:37:11 -0700
American Brain Tumor Association Offers “Top Ten” Brain Tumor Facts
Thu, 03 May 2012 09:51:23 -0700
Boy who battled brain tumor throws out first pitch
Sat, 19 May 2012 22:14:58 -0700
Stem cells boost brain tumor treatments for some patients, study finds
Thu, 10 May 2012 08:39:11 -0700
Houston hospital live tweets brain tumor surgery
Wed, 09 May 2012 06:00:14 -0700
Golf Tourney & Auction To Benefit Brain Tumor Victim
Fri, 18 May 2012 06:05:34 -0700
Beloved Wellwood middle school counselor and young mother loses battle with cancer
Fri, 18 May 2012 14:45:22 -0700
Brain tumor survivor, family run for charity
Tue, 01 May 2012 17:24:16 -0700

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
  
 
Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology. ProbeSetAnalyzer.com, a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring / Summer 2012
Breakthroughs



It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.


Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.


Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.


Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2012 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2012 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:5/20/2012 1:07:07 AM PST]



Recent Headlines
University of California, Los Angeles Neuro-Oncology : A Comprehensive Brain Tumor Program
Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Research and Markets: Metastatic Brain Tumor - Pipeline Review, H1 2012
Tue, 08 May 2012 09:01:00 -0700
Brain Tumor Patient Community Delivers Priorities to Congress: Invest in Research and Ensure Access to Oral Chemotherapy
Mon, 07 May 2012 05:02:47 -0700
She's a brain tumor survivor and she wants to tell the world her story
Wed, 16 May 2012 17:37:11 -0700
American Brain Tumor Association Offers “Top Ten” Brain Tumor Facts
Thu, 03 May 2012 09:51:23 -0700
Boy who battled brain tumor throws out first pitch
Sat, 19 May 2012 22:14:58 -0700
Stem cells boost brain tumor treatments for some patients, study finds
Thu, 10 May 2012 08:39:11 -0700
Houston hospital live tweets brain tumor surgery
Wed, 09 May 2012 06:00:14 -0700
Golf Tourney & Auction To Benefit Brain Tumor Victim
Fri, 18 May 2012 06:05:34 -0700
Beloved Wellwood middle school counselor and young mother loses battle with cancer
Fri, 18 May 2012 14:45:22 -0700
Brain tumor survivor, family run for charity
Tue, 01 May 2012 17:24:16 -0700

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
  
 
Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology. ProbeSetAnalyzer.com, a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring / Summer 2012
Breakthroughs



It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.


Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.


Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.


Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2012 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2012 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:5/20/2012 1:07:07 AM PST]

 
University of California, Los Angeles Neuro-Oncology : A Comprehensive Brain Tumor Program
Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Research and Markets: Metastatic Brain Tumor - Pipeline Review, H1 2012
Tue, 08 May 2012 09:01:00 -0700
Brain Tumor Patient Community Delivers Priorities to Congress: Invest in Research and Ensure Access to Oral Chemotherapy
Mon, 07 May 2012 05:02:47 -0700
She's a brain tumor survivor and she wants to tell the world her story
Wed, 16 May 2012 17:37:11 -0700
American Brain Tumor Association Offers “Top Ten” Brain Tumor Facts
Thu, 03 May 2012 09:51:23 -0700
Boy who battled brain tumor throws out first pitch
Sat, 19 May 2012 22:14:58 -0700
Stem cells boost brain tumor treatments for some patients, study finds
Thu, 10 May 2012 08:39:11 -0700
Houston hospital live tweets brain tumor surgery
Wed, 09 May 2012 06:00:14 -0700
Golf Tourney & Auction To Benefit Brain Tumor Victim
Fri, 18 May 2012 06:05:34 -0700
Beloved Wellwood middle school counselor and young mother loses battle with cancer
Fri, 18 May 2012 14:45:22 -0700
Brain tumor survivor, family run for charity
Tue, 01 May 2012 17:24:16 -0700

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
  
 
Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology. ProbeSetAnalyzer.com, a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring / Summer 2012
Breakthroughs



It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.


Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.


Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.


Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2012 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2012 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:5/20/2012 1:07:07 AM PST]

W Hotel
Tiverton House
Luxe Hotel Sunset Boulevard
Double Tree, Wilshire Blvd
Beverly Hilton
Four Seasons, Belvery Wilshire

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Provider IQ) 1998-2012 SiliconMED North America

Copyright © 2012 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:5/20/2012 4:42:04 PM PST]